Jefferies Group’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Jefferies Group’s Portfolio JNCE Stock Details JNCE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$309K	Buy
2019 Q4	–	Sell
2019 Q3	$45K	Buy